| AID | Assay Name | Assay Type | Target | Powder Sample | Compounds |
|---|---|---|---|---|---|
| 1321 | Primary Cell-based HTS Assay for Inhibitors of Wee1 Degradation | Primary Assay (1X %INH) | Wee1 | No | 5 μM |
| 1410 | Confirmation cell-based HTS assay for inhibitors of Wee1 degradation | Confirmation Assay (3X %INH) | Wee1 | No | 5 μM |
| 1412 | Dose Response Cell-based Assay for Inhibitors of Wee1 Degradation. | Dose Response (3X EC50) | Wee1 | No | 10-point, 1:3 dilution starting at 50 μM |
| 1413 | Cytotoxicity counterscreen assay for inhibitors of Wee1 degradation. | Dose Response Counterscreen Assay (3X CC50) | Cytotoxicity | No | 10-point, 1:3 dilution starting at 50 μM |
| 1414 | Counterscreen assay for inhibitors of Wee1 degradation: dose response cell-based assay to identify inhibitors of cyclin B degradation | Dose Response Counterscreen (3X% EC50) | Cyclin B | No | 10-point, 1:3 dilution starting at 50 μM |
| 1807 | Summary of probe development efforts to identify inhibitors of Wee1 degradation | Summary | Wee1 | N/A | N/A |
| 2088 | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation | Late Stage | Wee1 | Yes | Various |
From: Small Molecule Inhibitors of Wee1 Degradation and Mitotic Entry
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.